Xeris Biopharma Holdings, Inc.
XERSDrug Manufacturers - Specialty & Generic
$10.75+1.03%As of Oct 29vs prior close
- Market cap
- $2B
- P/E (TTM)
- –
- From 52W high
- −3.41%
- EPS (LTM)
- -$0.10
- Revenue (LTM)
- $335.4M
- Net margin
- -5.12%
- Dividend yield
- 0.00%
Nomior Score
43
Steady ProfileSpeculativeBottom 36% of the scored universe
Growth69
Quality48
Value42
Momentum43
Resilience33
Growth
+70.20%revenue a year over 5 fiscal years
YE20 $20.4MLTM $335.4M
Connections
Revenue to profitQ2 YE26
The net loss was 34% of revenue, wider by 31 pts on a year.
Who owns it
2funds